Comparision study of two poly herbal formulation in type 2 diabetes mellitus (prameha)

A Comparitive Clinical Evaluation Of TriphalÄ?di Kaá¹£Ä?ya & MustÄ?di Kaá¹£Ä?ya On Kapha-Pittaja Prameha With Special Reference To Diabetes Mellitus-II In The Purview Of â?? Saá¹?tarpanottheá¹£u Gadeá¹£u YogÄ? â?¦â?¦â?¦â?¦..Prameheá¹£vapi Te PrayojyÄ?á¸¥â??

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053817

Enrollment

Registered

2023-06-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA:â?? 1. Patients willing to sign Consent Form for the clinical trial. 2. Patients between the age group of 18-70 years, irrespective of sex, caste, religion and socioeconomic status. 3. Patients who fulfill the diagnostic criteria of Pitta-kaphaja Prameha explained in Ä?yurvedika classics and Diagnostic criteria of Diabetes Mellitus Type-II ICMR guidelines 2018 - ï?·Symptoms of diabetes plus casual or random plasma glucose >= 200 mg/dl (Casual means without regard to time of last meal). ï?·PPBS >180mg/dl with upper range of 300 mg/dl. ï?·Fasting plasma glucose >= 126 mg/dl with upper range of 200 mg/dl. ï?·Glycated Haemoglobin >= 6.5% with upper range of 11.5%.

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA:- 1.Patients below 18 and after 70 years. 2.Cases with deformities that requires surgical treatment. 3.Patients with complications and contraindicated for treatment in Ä?yurvedika and modern texts. 4.Patients of Diabetes Mellitus Type1 5.Patients on allopathic anti-diabetic drug. 6.Malignancy, other endocrinal disorders, chronic infectious diseases etc. 7.Pregnant and lactating mother. Patients having any serious illness like cardiovascular diseases, renal diseases etc.

Design outcomes

Primary

Measure	Time frame
Primary outcome: Improvement in sign and symptoms of the disease and changes in investigation parameters i.e. FBS, PPBS, HbA1c and Urine R/MTimepoint: 60 DAYS((BEFORE TREATMENT AND AFTER TREATMENT))	—

Secondary

Measure	Time frame
Secondary outcome: Improvement in quality of life as per Ä?yurvedika text in terms of Agni, Bala, Nidra, Kostha suddhi etc. and changes in other Lab. Investigation LFT, RFT, CBC,ESR,LIPID PROFILE etc.Timepoint: 60 DAYS(BEFORE TREATMENT AND AFTER TREATMENT)	—

Countries

India

Contacts

Public ContactDr Abhinesh

National Institute Of Ayurveda Deemed To Be University,Jaipur

guptadr.nisha@gmail.com9982082832

Outcome results